Preconditioning the Ocular Surface with UCMSC-Derived Exosomes Preserves Corneal Integrity in Experimental Dry Eye
Background/Objectives: Dry eye disease (DED) disrupts corneal epithelial homeostasis and may cause progressive ocular surface injury. Although MSC-derived exosomes have shown therapeutic efficacy after the establishment of DED, their prophylactic potential remains unclear. This study evaluated whether topical UCMSC-derived exosome preconditioning protects the cornea against subsequent aqueous-deficient DED. Methods: Forty female Sprague-Dawley rats aged six to eight weeks were allocated to the prophylactic exosome treatment (PTE) or untreated control groups. PTE rats received low-concentration UCMSC-derived exosome eye drops once daily for 14 days before unilateral lacrimal gland excision; treatment ceased immediately after surgery. Clinical, AS-OCT, histological, ZO-1, Ki-67, and TUNEL assessments were conducted before induction and through Day 14. Corneal TNF-α, IL-1β, TGF-β, and IL-10 expression was measured via qPCR at Day 0. Results: PTE reduced overall corneal neovascularization (mean vessel length, 46.91 vs. 117.06 µm; p = 0.015) and epithelial thickening (54.01 vs. 71.80 µm; p = 0.006). ZO-1 immunoreactivity was significantly greater in the PTE group (D14: 0.678 vs. 0.154; p < 0.001), while there were significantly fewer TUNEL-positive cells at D0 (17.5 vs. 59.5; p < 0.001) and D7 (16.25 vs. 57.25; p < 0.001). Fluorescein staining, stromal thickness, Ki-67 immunoreactivity, and cytokine transcription did not differ significantly between groups. Conclusions: Preconditioning with topical UCMSC-derived exosomes conferred selective corneal protection after dosing ended, characterized by reduced angiogenesis and apoptosis and better preservation of epithelial thickness and tight-junction integrity. These findings support prophylactic exosome exposure as a proof-of-concept strategy for enhancing corneal resilience before predictable ocular surface injury in this severe experimental model; however, the absence of a vehicle-treated control and limited mechanistic characterization warrant further investigation before clinical translation.
Authors
- Zih-Rou Huang
- Chris Tsai
- Sze-Min Chan (ORCID: https://orcid.org/0009-0005-9494-9501)
- Chung-Tien Lin
- Tai-Ping Lee
Institutions
- National Taiwan University (TW)
Publication Details
- Journal
- Pharmaceutics
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3390/pharmaceutics18111480
- Primary Topic
- Ocular Surface and Contact Lens
- Type
- article
- Field-Weighted Citation Impact
- 0.00